Clinical Trial Update: ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism [Phase 4]

View source ↗

Summary

Amgen completed a Phase 4 clinical trial update aimed at optimizing treatment of secondary hyperparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED